These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15225833)

  • 1. Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer.
    Jacobs ET; Giuliano AR; Martínez ME; Hollis BW; Reid ME; Marshall JR
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):533-7. PubMed ID: 15225833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
    Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
    PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk.
    Deschasaux M; Souberbielle JC; Latino-Martel P; Sutton A; Charnaux N; Druesne-Pecollo N; Galan P; Hercberg S; Le Clerc S; Kesse-Guyot E; Ezzedine K; Touvier M
    Br J Nutr; 2016 Jan; 115(2):305-14. PubMed ID: 26568368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case-control study.
    Gilbert R; Bonilla C; Metcalfe C; Lewis S; Evans DM; Fraser WD; Kemp JP; Donovan JL; Hamdy FC; Neal DE; Lane JA; Smith GD; Lathrop M; Martin RM
    Cancer Causes Control; 2015 Feb; 26(2):205-218. PubMed ID: 25488826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating 25-hydroxyvitamin D, vitamin D binding protein and risk of advanced and lethal prostate cancer.
    Yuan C; Shui IM; Wilson KM; Stampfer MJ; Mucci LA; Giovannucci EL
    Int J Cancer; 2019 May; 144(10):2401-2407. PubMed ID: 30411792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of decreased Vitamin D 1alpha-hydroxylase activity in prostate cancer cells.
    Ma JF; Nonn L; Campbell MJ; Hewison M; Feldman D; Peehl DM
    Mol Cell Endocrinol; 2004 Jun; 221(1-2):67-74. PubMed ID: 15223133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
    Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
    J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer.
    Gann PH; Ma J; Hennekens CH; Hollis BW; Haddad JG; Stampfer MJ
    Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):121-6. PubMed ID: 8850273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.
    Platz EA; Leitzmann MF; Hollis BW; Willett WC; Giovannucci E
    Cancer Causes Control; 2004 Apr; 15(3):255-65. PubMed ID: 15090720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma 25-hydroxy vitamin D and subsequent prostate cancer risk in a nested Case-Control study in Japan: The JPHC study.
    Sawada N; Inoue M; Iwasaki M; Yamaji T; Shimazu T; Sasazuki S; Tsugane S
    Eur J Clin Nutr; 2017 Jan; 71(1):132-136. PubMed ID: 27759068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of circulating retinol, vitamin E, and 1,25-dihydroxyvitamin D with prostate cancer diagnosis, stage, and grade.
    Gilbert R; Metcalfe C; Fraser WD; Donovan J; Hamdy F; Neal DE; Lane JA; Martin RM
    Cancer Causes Control; 2012 Nov; 23(11):1865-73. PubMed ID: 22926301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
    Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    Shui IM; Mondul AM; Lindström S; Tsilidis KK; Travis RC; Gerke T; Albanes D; Mucci LA; Giovannucci E; Kraft P;
    Cancer; 2015 Jun; 121(12):1949-56. PubMed ID: 25731953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk.
    Travis RC; Perez-Cornago A; Appleby PN; Albanes D; Joshu CE; Lutsey PL; Mondul AM; Platz EA; Weinstein SJ; Layne TM; Helzlsouer KJ; Visvanathan K; Palli D; Peeters PH; Bueno-de-Mesquita B; Trichopoulou A; Gunter MJ; Tsilidis KK; Sánchez MJ; Olsen A; Brenner H; Schöttker B; Perna L; Holleczek B; Knekt P; Rissanen H; Yeap BB; Flicker L; Almeida OP; Wong YYE; Chan JM; Giovannucci EL; Stampfer MJ; Ursin G; Gislefoss RE; Bjørge T; Meyer HE; Blomhoff R; Tsugane S; Sawada N; English DR; Eyles DW; Heath AK; Williamson EJ; Manjer J; Malm J; Almquist M; Marchand LL; Haiman CA; Wilkens LR; Schenk JM; Tangen CM; Black A; Cook MB; Huang WY; Ziegler RG; Martin RM; Hamdy FC; Donovan JL; Neal DE; Touvier M; Hercberg S; Galan P; Deschasaux M; Key TJ; Allen NE
    Cancer Res; 2019 Jan; 79(1):274-285. PubMed ID: 30425058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association among plasma 1,25(OH)
    Ramakrishnan S; Steck SE; Arab L; Zhang H; Bensen JT; Fontham ETH; Johnson CS; Mohler JL; Smith GJ; Su LJ; Woloszynska A
    Prostate; 2019 Jul; 79(10):1117-1124. PubMed ID: 31077420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of cytochrome P450 enzymes in prostate cancer development and treatment.
    Chen TC; Sakaki T; Yamamoto K; Kittaka A
    Anticancer Res; 2012 Jan; 32(1):291-8. PubMed ID: 22213318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of the Insulin-Like Growth Factor Axis and Vitamin D in Prostate Cancer Risk in the Prostate Cancer Prevention Trial.
    Miles FL; Goodman PJ; Tangen C; Torkko KC; Schenk JM; Song X; Pollak M; Thompson IM; Neuhouser ML
    Nutrients; 2017 Apr; 9(4):. PubMed ID: 28417914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study.
    Shui IM; Mucci LA; Kraft P; Tamimi RM; Lindstrom S; Penney KL; Nimptsch K; Hollis BW; Dupre N; Platz EA; Stampfer MJ; Giovannucci E
    J Natl Cancer Inst; 2012 May; 104(9):690-9. PubMed ID: 22499501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer.
    Bertone-Johnson ER; Chen WY; Holick MF; Hollis BW; Colditz GA; Willett WC; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1991-7. PubMed ID: 16103450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade.
    Gilbert R; Metcalfe C; Fraser WD; Donovan J; Hamdy F; Neal DE; Lane JA; Martin RM
    Int J Cancer; 2012 Sep; 131(5):1187-96. PubMed ID: 22033893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.